New hope for patients with rare, Hard-to-Treat blood disorders
Disease control
Recruiting now
This study is testing whether the drug ruxolitinib can help control rare blood disorders where the body makes too many eosinophils, a type of white blood cell. It will involve about 10 adults whose conditions have not responded well to standard treatments like steroids. The main …
Phase: PHASE2 • Sponsor: William Shomali • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC